The WACC of Atara Biotherapeutics Inc (ATRA) is 17.7%.
| Range | Selected | |
| Cost of equity | 6.60% - 8.50% | 7.55% |
| Tax rate | -% - -% | -% |
| Cost of debt | 7.00% - 49.90% | 28.45% |
| WACC | 6.8% - 28.7% | 17.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.59 | 0.64 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.60% | 8.50% |
| Tax rate | -% | -% |
| Debt/Equity ratio | 0.96 | 0.96 |
| Cost of debt | 7.00% | 49.90% |
| After-tax WACC | 6.8% | 28.7% |
| Selected WACC | 17.7% | |